What happens after the diagnosis of non-seizure symptoms in Dravet syndrome? A Brazilian national survey
Epilepsy & Behavior · 2025
DOI: 10.1016/j.yebeh.2025.110717 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2025. Verfasst von Barbara Fialho und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil. Electronic address: barbara.fialho@fm.usp.br. Hauptthemen laut MEDLINE: Epilepsies, Myoclonic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: FAPESP.
Abstract (Originalsprache)
OBJECTIVE: Dravet syndrome (DS) is a severe developmental and epileptic encephalopathy marked by drug-resistant epilepsy and core neurodevelopmental non-seizure symptoms (NSS). This study evaluated the access to supportive therapies and inclusive education for these neurodevelopmental disorders, based on caregiver-reported data. METHODS: A cross-sectional, caregiver-reported online survey was distributed to families enrolled in the Brazil Dravet Association. It included questions addressing demographics, epilepsy, neurodevelopment, and access to rehabilitation. RESULTS: Responses from 139 caregivers (91.4% mothers) caring for 140 individuals (138 unrelated) with DS were analyzed. The most frequently reported NSS included intellectual disability [92.1% (128/139], communication impairments [87.9% (116/132)], motor difficulties [77.3% (102/132)], behavioral problems [70.8% (97/137), and autism spectrum disorder [57.3% (78/136)]. Access to rehabilitation was variable: 72.5% (74/102) received physiotherapy or occupational therapy, 65.5% (76/116) received speech therapy, and 51.3% (40/78) of those with ASD had behavioral interventions. Thirty-one patients (24.2%) accessed specialized educational settings. Weekly sessions of motor rehabilitation were reported by 64.7% patients, speech therapy by 56% and behavioral therapy by 51.3%. Considering all patients that received any type of support, 83.9% (94/112) had access to the private system (integral or partially). NSS worsening with sodium channel blockers was reported by 85% of caregivers, with 33.4% describing permanent deterioration. CONCLUSIONS: Although NSS are recognized in DS, access to adequate and equitable therapeutic and educational support remains limited showing a fragmented system. A multidisciplinary, system-integrated approach is needed to address unmet needs and mitigate long-term functional decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil. Electronic address: barbara.fialho@fm.usp.br.
- Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.
- Associação Dravet Brazil. Electronic address: fernanada.melo@fm.usp.br.
- Associação Dravet Brazil.
- Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, SP, Brazil. Electronic address: kette.…
Förderung
- FAPESP
Zitieren
APA
Fialho, B., Melo, F., França Mazzei Nogueira, C. M., de Souza Pereira, B., & Valente, K. D. (2025). What happens after the diagnosis of non-seizure symptoms in Dravet syndrome? A Brazilian national survey. Epilepsy & Behavior. https://doi.org/10.1016/j.yebeh.2025.110717
Vancouver
Fialho B, Melo F, França Mazzei Nogueira CM, de Souza Pereira B, Valente KD. What happens after the diagnosis of non-seizure symptoms in Dravet syndrome? A Brazilian national survey. Epilepsy & Behavior. 2025. doi:10.1016/j.yebeh.2025.110717
BibTeX
@article{Fialho2025,
author = {Fialho, Barbara and Melo, Fernanda and França Mazzei Nogueira, Claudia Maria and de Souza Pereira, Bárbara and Valente, Kette D},
title = {What happens after the diagnosis of non-seizure symptoms in Dravet syndrome? A Brazilian national survey},
journal = {Epilepsy & Behavior},
year = {2025},
doi = {10.1016/j.yebeh.2025.110717}
}
EUVIMED